Issues related to drug pricing. Issues related to the 340B Drug Discount Program. Issues related to Inflation Reduction Act of 2022 (PL 117-169) implementation Issues related to Medicare and Medicaid coverage and reimbursement; Issues related to the expiration/extension of Priority Review Vouchers (PRVs) for rare disease; Issues relating to privacy and securing the data of and personal information of consumers General education on policies effecting development of pharmaceuticals, FDA approval and reimbursement.
Lobbyists:
mr MATTHEW LAWRENCE BERZOK — covered position: LD and Chief Counsel, Rep. Bart Stupak; LA, Rep. Peter Deutsch
NICK KOLOVOS — covered position: LA and Counsel, Rep. Anna Eshoo
Government entities lobbied:HOUSE OF REPRESENTATIVES; SENATE
MMM — Medicare/Medicaid
Issues related to drug pricing. Issues related to the 340B Drug Discount Program. Issues related to Inflation Reduction Act of 2022 (PL 117-169) implementation Issues related to Medicare and Medicaid coverage and reimbursement; Issues related to the expiration/extension of Priority Review Vouchers (PRVs) for rare disease;
Lobbyists:
mr MATTHEW LAWRENCE BERZOK — covered position: LD and Chief Counsel, Rep. Bart Stupak; LA, Rep. Peter Deutsch
NICK KOLOVOS — covered position: LA and Counsel, Rep. Anna Eshoo
Government entities lobbied:HOUSE OF REPRESENTATIVES; SENATE
pac.dog is a free, independent, non-partisan research tool. Every candidate, committee, bill, vote, member, and nonprofit on this site is mirrored from primary U.S. government sources (FEC, congress.gov, govinfo.gov, IRS) and each state's Secretary of State / election commission — no third-party data vendors, no paywall, no editorial intermediation. Citations to the originating source are on every detail page.